HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.

Abstract
The initial attachment of influenza virus to cells is the binding of hemagglutinin (HA) to the sialyloligosaccharide receptor; therefore, the small molecules that inhibit the sugar-protein interaction are promising as HA inhibitors to prevent the infection. We herein demonstrate that sialic acid-mimic heptapeptides are identified through a selection from a primary library against influenza virus HA. In order to obtain lead peptides, an affinity selection from a phage-displayed random heptapeptide library was performed with the HAs of the H1 and H3 strains, and two kinds of the HA-binding peptides were identified. The binding of the peptides to HAs was inhibited in the presence of sialic acid, and plaque assays indicated that the corresponding N-stearoyl peptide strongly inhibited infections by the A/Aichi/2/68 (H3N2) strain of the virus. Alanine scanning of the peptides indicated that arginine and proline were responsible for binding. The affinities of several mutant peptides with single-amino-acid substitutions against H3 HA were determined, and corresponding docking studies were performed. A Spearman analysis revealed a correlation between the affinity of the peptides and the docking study. These results provide a practicable method to design of peptide-based HA inhibitors that are promising as anti-influenza drugs.
AuthorsTeruhiko Matsubara, Ai Onishi, Daisuke Yamaguchi, Toshinori Sato
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 24 Issue 5 Pg. 1106-14 (Mar 01 2016) ISSN: 1464-3391 [Electronic] England
PMID26833245 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • Antiviral Agents
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Oligopeptides
  • Peptide Library
  • N-Acetylneuraminic Acid
Topics
  • Animals
  • Antiviral Agents (chemistry, metabolism, pharmacology)
  • Cell Line
  • Dogs
  • Hemagglutinin Glycoproteins, Influenza Virus (metabolism)
  • Humans
  • Influenza A virus (drug effects, physiology)
  • Influenza, Human (metabolism, prevention & control)
  • Molecular Docking Simulation
  • Mutagenesis, Site-Directed
  • N-Acetylneuraminic Acid (analogs & derivatives, pharmacology)
  • Oligopeptides (chemistry, genetics, pharmacology)
  • Orthomyxoviridae Infections (metabolism, prevention & control)
  • Peptide Library

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: